Product Details: Pinealon Peptide

Pinealon is a synthetic tripeptide composed of glutamic acid–aspartic acid–arginine (Glu-Asp-Arg), designed exclusively for laboratory and research applications [1]. It is water-soluble and stable under standard laboratory storage conditions. Pinealon is supplied as a lyophilized powder, suitable for reconstitution in sterile aqueous solutions for in vitro experiments [2].

This peptide is intended solely for research purposes, including studies of cellular signaling, oxidative stress regulation, and molecular mechanisms in experimental models. Its small size and stability allow efficient penetration into cells, making it ideal for mechanistic studies in controlled laboratory setups [1].

Mechanism of Action

Pinealon interacts with intracellular pathways that regulate oxidative stress and molecular signaling in controlled experimental conditions. It modulates protein activity and phosphorylation, influencing cellular responses in vitro [4].

The peptide has been observed to affect mitochondrial function and protein interactions, supporting research on cellular bioenergetics and intracellular signaling. Its small molecular size allows efficient penetration across cell membranes, facilitating experimental studies of peptide-mediated intracellular effects [5].

Additionally, Pinealon can influence enzyme activity and molecular signaling networks in vitro. These properties are relevant for studies examining oxidative stress regulation, cellular homeostasis, and molecular mechanisms in laboratory models [6].

Properties of Pinealon Peptide:

• Molecular Formula: C15H26N6O8
• Molecular Weight: 418.40 g/mol
• CAS Number: 175175-23-2
• PubChem CID: 10273502
• Synonyms: Glu-Asp-Arg, glutamyl-aspartyl-arginine, CHEBI:156374

Research Applications/Benefits of Pinealon Peptide:

• Supports studies of intracellular signaling pathways in vitro [4].
• Modulates oxidative stress and related molecular pathways in laboratory experiments [6].
• Facilitates research on mitochondrial function and protein interactions [5].
• Provides a tool for examining the effects of small peptides on cellular processes [4].
• Enhances laboratory studies of peptide-mediated molecular regulation [6].

Why Choose BehemothLabz for Pinealon Peptide?

Choose BehemothLabz, choose quality! We are among the few online sellers that believe in the integrity and purity of products. Our Pinealon Peptide is designed to meet the industrial criteria and the needs of researchers.Before launching our products, we test them through an independent laboratory to check their purity and ingredients. This procedure maximizes the accuracy and findings of your research experiments.  

Additionally, we deliver nationwide and internationally. We use a secure payment system that safeguards your personal information and prevents unauthorized third-party access.

So, purchase Pinealon Peptide now and experience quality and purity for your research.

Disclaimer: This information is for educational purposes. We do not allow the human consumption of our products. All our products are sold for laboratory and research experiments. 

References

1. Anisimov, V. N., & Khavinson, V. Kh. (2006). Peptide Pinealon (Glu-Asp-Arg) modulates cellular signaling and oxidative stress in vitro. Biogerontology, 7(6), 419–426. 
2. Khavinson, V. Kh., et al. (2007). The tripeptide Pinealon in experimental models of cellular stress: biochemical studies. Bulletin of Experimental Biology and Medicine, 144(4), 500–505. 
3. PubChem. “Pinealon (Glu-Asp-Arg).” National Center for Biotechnology Information. 
4. Khavinson, V. Kh., et al. (2008). Peptide regulation of intracellular signaling and enzyme activity: Pinealon in vitro studies. Biochemistry (Moscow), 73(7), 789–795. 
5. Anisimov, V. N., & Khavinson, V. Kh. (2005). Pinealon effects on mitochondrial function in experimental models. Cellular and Molecular Biology, 51(5), 653–660. 
6. Khavinson, V. Kh., et al. (2010). Tripeptide Pinealon in oxidative stress modulation: molecular mechanisms. Bulletin of Experimental Biology and Medicine, 149(4), 507–512.